🇺🇸 FDA
Pipeline program

Treprostinil Inhalation Solution

14-0490

Phase 2 small_molecule terminated

Quick answer

Treprostinil Inhalation Solution for Respiratory Distress Syndrome, Adult is a Phase 2 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Respiratory Distress Syndrome, Adult
Phase
Phase 2
Modality
small_molecule
Status
terminated

Clinical trials